MAPK1 and neoplasm: Common markers of in vivo dormancy include cell cycle reporters and the ratio of phosphorylated p38 to phosphorylated extracellular signal-regulated kinase (ERK), which can be validated for both cellular and tumor dormancy using in vitro models (12).